Aggregator

RISR hits a 52-week high amid rising Treasury yields and hawkish Fed expectations. More upside ahead?

We identify which players, coaches and units are most responsible for their teams' poor starts

Tyler Sullivan picks every game on the Week 4 schedule, plus five locks against the spread

Space ETFs are set to regain momentum as Starship succeeds and space investment surges, but volatility clouds the sector's outlook.

Key PointsWall Street is divided over Tesla's third quarter vehicle delivery estimates.

Key PointsWall Street is divided over Tesla's third quarter vehicle delivery estimates.

Key PointsWall Street is divided over Tesla's third quarter vehicle delivery estimates.

Between them, Cody Gakpo and Alexander Isak have scored five of Liverpool's seven league goals this season so their injuries during the international break could prove costly.

Key PointsBroadcom maintains high margins through its dominance in networking hardware and its strategic expansion into enterprise infrastructure software.

Key PointsBroadcom maintains high margins through its dominance in networking hardware and its strategic expansion into enterprise infrastructure software.

Key PointsBroadcom maintains high margins through its dominance in networking hardware and its strategic expansion into enterprise infrastructure software.

Pep Guardiola won 16 major honors as Man City manager. They all now count for nothing after the Premier League found the club guilty of systematically breaking financial rules.

BBC Sport takes a look at the key questions following the guilty verdicts handed down to Manchester City.

BBC Sport takes a look at the key questions following the guilty verdicts handed down to Manchester City.

Borgata Sportsbook promo code for new users: CBS100 to bet $20, get $100 instantly in bonus bets

Unsure whether AI is a bubble or a boom? A core-satellite ETF strategy can help investors pursue AI growth without making an all-or-nothing bet.

(RTTNews) - Wednesday, Silexion Therapeutics (SLXN) said the first patient has been dosed in its global Phase 2/3 trial evaluating SIL204 in patients with locally advanced pancreatic cancer (LAPC).

(RTTNews) - Wednesday, Silexion Therapeutics (SLXN) said the first patient has been dosed in its global Phase 2/3 trial evaluating SIL204 in patients with locally advanced pancreatic cancer (LAPC).

(RTTNews) - Caterpillar Inc. (CAT), a construction, mining, and other engineering equipment maker, said on Wednesday that it plans to invest around $1 billion in North Carolina to expand production capacity for products that support its growing Cat CompactSM business.

(RTTNews) - Caterpillar Inc. (CAT), a construction, mining, and other engineering equipment maker, said on Wednesday that it plans to invest around $1 billion in North Carolina to expand production capacity for products that support its growing Cat CompactSM business.